-
Product Insights
NewLikelihood of Approval Analysis for Epilepsy
Overview How likely is it that the drugs in Epilepsy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Epilepsy Overview Epilepsy is a group of non-communicable neurological disorders characterized by recurrent...
-
Product Insights
NewLikelihood of Approval Analysis for Childhood Epilepsy
Overview How likely is it that the drugs in Childhood Epilepsy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Childhood Epilepsy Overview Childhood epilepsy is a neurological disorder characterized by recurring...
-
Product Insights
NewLikelihood of Approval Analysis for Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Overview How likely is it that the drugs in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Apinocaltamide in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Apinocaltamide in Epilepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Apinocaltamide in Epilepsy Drug Details: Apinocaltamide (NBI-827104) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMS-986368 in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMS-986368 in Epilepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMS-986368 in Epilepsy Drug Details: BMS-986368 (CC-97489) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-044 in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-044 in Epilepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-044 in Epilepsy Drug Details: OPL-044 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CB-03 in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CB-03 in Epilepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CB-03 in Epilepsy Drug Details: CB-03 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brivaracetam in Childhood Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brivaracetam in Childhood Epilepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brivaracetam in Childhood Epilepsy Drug Details: Brivaracetam (Briviact / Brivlera) the 4-n-propyl...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMO-01 in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMO-01 in Epilepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AMO-01 in Epilepsy Drug Details: AMO-01 (TLN-4601) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Histamine Dihydrochloride in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Histamine Dihydrochloride in Epilepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Histamine Dihydrochloride in Epilepsy Drug Details: Histamine dihydrochloride is under development of...